Safety of Obinutuzumab in children with autoimmune encephalitis and early B cell repopulation on rituximab.

The study objective was to report the use and safety of obinutuzumab in rituximab-resistant children with neurological inflammatory diseases.

Source: Pediatric Neurology - April 18, 2024 Category: Neurology Authors: A.T. Nguyen, C. Cotteret, C. Gins, E. Sarda, C. Durrleman, B. Mesples, J. Bustamante, C. Fayard, S. Cisternino, I. Desguerre, M. Aubart Tags: Research Paper Source Type: research